Comparative observation on changes in serum lipid profile level in patients undergoing snehana (internal oleation) with pure ghee in one group and Mahatiktaka ghrita (medicated ghee)in other group

Phase 2

Completed

• Conditions: Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: null- Patients suffering from skin disorder

• Registration Number: CTRI/2017/09/009589
• Lead Sponsor: Central Council For Research in Ayurvedic Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Patients with either sex aged between 18- 40 years.

2.Patients suffering from skin disorder (like eczema, psoriasis, acne vulgaris) in which Snehana and virechana is indicated.

3.Willing and able to participate in the study

Exclusion Criteria

1.Age <18yrs and >40yrs

2.Patients suffering from Peptic ulcer, Hypertension, Diabetes Mellitus

3.Patients suffering from hyperlipidemia (lipid profile level more than normal range)

4.Patients with concurrent hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.

5.Known case of hypothyroidism.

6.Patients with evidence of malignancy.

7.Patients on prolonged ( > 6 weeks) medication with corticosteroids, diuretics, antidislipidaemic, etc. or any other drugs that may have an influence on the outcome of the study.

8.Pregnant / lactating woman.

9.Patients who are currently participating in any other clinical trial

10.Any other condition which the Principal Investigator thinks may jeopardize the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in fasting serum lipid profileTimepoint: from baseline to next day of virechana

Secondary Outcome Measures

Name	Time	Method
comparison of Changes in Sr. Cholesterol and Sr. Triglycerides in two groupsTimepoint: from baseline to next day of virechana